Prostate Cancer
Studies conducted in Germany and the United States have updated our knowledge about prostate cancer
Published in Oncology Business Week, February 11th, 2007
Study 1: New research, "Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence," is the subject of a report. According to a study from Germany, "Prostate cancer biology varies from locally confined tumors with low risk for relapse to tumors with high risk for progression even after radical prostatectomy. Currently, there are no reliable biomarkers to predict tumor relapse and poor clinical outcome."
"In this study, we correlated expression patterns of the androgen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Acute Myeloid Leukemia
Xanthus receives orphan drug designation of Xanafide for treating acute myeloid leukemia - Allergy & Immunology
Dynavax reports interim Tolamba ragweed allergy results from DARTT trial - Angiogenesis
Recent findings from Bayer Healthcare, Department of Cancer Biology highlight research in angiogenesis - Bladder Cancer Therapy
Research on bladder cancer therapy detailed by scientists at Memorial Sloan Kettering Cancer Center - Breast Cancer
National networks create online report to educate breast cancer patients on HER2 testing - Breast Cancer Immunology
Research from Introgen Therapeutics, Inc. in the area of breast cancer immunology published - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
